| 418.61 -3.45 (-0.82%) | 06-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 510.76 |
1-year : | 540.08 |
| Resists | First : | 437.29 |
Second : | 462.39 |
| Pivot price | 426.31 |
|||
| Supports | First : | 396.67 | Second : | 330.03 |
| MAs | MA(5) : | 414.1  |
MA(20) : | 426.4 |
| MA(100) : | 472.08 |
MA(250) : | 495.64 |
|
| MACD | MACD : | -9.9 |
Signal : | -10.1 |
| %K %D | K(14,3) : | 44.5 |
D(3) : | 35 |
| RSI | RSI(14): 43.1 |
|||
| 52-week | High : | 603.88 | Low : | 396.67 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ISRG ] has closed above bottom band by 38.3%. Bollinger Bands are 8.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 424.63 - 426.8 | 426.8 - 428.46 |
| Low: | 412.06 - 414.35 | 414.35 - 416.11 |
| Close: | 416.47 - 420.3 | 420.3 - 423.23 |
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Mon, 08 Jun 2026
ISRG: Affiliate files Form 144 to sell 665 shares under 10b5-1 - Stock Titan
Wed, 03 Jun 2026
Why the Market Dipped But Intuitive Surgical, Inc. (ISRG) Gained Today - Yahoo Finance
Mon, 01 Jun 2026
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Wed, 27 May 2026
Intuitive Surgical Inc Stock (ISRG) Moved Down by 3.28% on May 27: Drivers Behind the Movement - TradingKey
Tue, 26 May 2026
Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy? - Yahoo Finance
Thu, 21 May 2026
Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 354 (M) |
| Shares Float | 352 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 89.2 (%) |
| Shares Short | 6,710 (K) |
| Shares Short P.Month | 6,670 (K) |
| EPS | 8.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 49.31 |
| Profit Margin | 28.1 % |
| Operating Margin | 30.8 % |
| Return on Assets (ttm) | 10.2 % |
| Return on Equity (ttm) | 17.2 % |
| Qtrly Rev. Growth | 23 % |
| Gross Profit (p.s.) | 19.82 |
| Sales Per Share | 29.87 |
| EBITDA (p.s.) | 10.98 |
| Qtrly Earnings Growth | 18.7 % |
| Operating Cash Flow | 3,360 (M) |
| Levered Free Cash Flow | 2,250 (M) |
| PE Ratio | 50.98 |
| PEG Ratio | 2.2 |
| Price to Book value | 8.51 |
| Price to Sales | 14.06 |
| Price to Cash Flow | 44.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|